“…Hypotheses such as production of an abnormal protein with altered binding affinity and/or capacity (4, 5, 11, 12, 15, 16, 18, 20), presence of an abnormal substance interfering with TR-binding to TBG (5) or absence of normally present extraneous inhibitor of T&-protein interaction (20), abnormality in the mechanism controlling TBG synthesis and possible degradation resulting in quantitative variations in TBG concentration (5,12,15,18,20), and presence of two types of TBG controlled by different genes (5), have been considered. Based on the model of genetic control of protein synthesis in bacteria, structural gene mutations (4,5,11,16,18,20), mutations at the control sites (repressor) or operator (5,16,18), and structural gene duplication resulting in double quantity of dose of a gene (16,18) have been also considered.…”